Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

420060

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Streptococcus: Babies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what cost benefit assessment his Department has made of a policy of providing Group B strep tests to new-born babies on the NHS.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	10748
answer	answer is ministerial correction date of answer 19/10/2015 answer text <p>Routine testing of babies for Group B Streptococcus (GBS) infection is not recommended. Therefore, no cost benefit assessment has been made by the Department on providing GBS tests to newborn babies.</p><br /><p>A search of the Department’s Ministerial correspondence database has identified 41 items of correspondence received since 1 January 2015 on GBS. This correspondence relates mainly to offering testing for GBS carriage in pregnancy.</p><br /><p>If a woman has previously had a baby with GBS, her maternity team will either monitor the health of her newborn baby closely for at least 12 hours after birth, or treat them with antibiotics until blood tests confirm whether or not GBS is present. The Department’s policy is not to offer antenatal screening for GBS carriage. This is based on advice from the UK National Screening Committee the body responsible for advising Ministers and the National Health Service in all four countries about all aspects of screening policy, and their advice is because there is insufficient evidence to demonstrate that the benefits to be gained from screening would outweigh the harms.</p> answering member constituency Ipswich answering member printed Ben Gummer grouped question UIN 10749 10750 question first answered 19/10/2015 14:14:57 answering member 3988 label Biography information for Ben Gummer
tabling member	411 label Biography information for Mr Barry Sheerman

420061

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Streptococcus: Babies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent representations he has received on the provision of Group B strep tests for new-born babies.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	10749
answer	answer is ministerial correction date of answer 19/10/2015 answer text <p>Routine testing of babies for Group B Streptococcus (GBS) infection is not recommended. Therefore, no cost benefit assessment has been made by the Department on providing GBS tests to newborn babies.</p><br /><p>A search of the Department’s Ministerial correspondence database has identified 41 items of correspondence received since 1 January 2015 on GBS. This correspondence relates mainly to offering testing for GBS carriage in pregnancy.</p><br /><p>If a woman has previously had a baby with GBS, her maternity team will either monitor the health of her newborn baby closely for at least 12 hours after birth, or treat them with antibiotics until blood tests confirm whether or not GBS is present. The Department’s policy is not to offer antenatal screening for GBS carriage. This is based on advice from the UK National Screening Committee the body responsible for advising Ministers and the National Health Service in all four countries about all aspects of screening policy, and their advice is because there is insufficient evidence to demonstrate that the benefits to be gained from screening would outweigh the harms.</p> answering member constituency Ipswich answering member printed Ben Gummer grouped question UIN 10748 10750 question first answered 19/10/2015 14:14:57 answering member 3988 label Biography information for Ben Gummer
tabling member	411 label Biography information for Mr Barry Sheerman

420062

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Streptococcus: Babies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his policy is on providing Group B strep tests for new-born babies.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	10750
answer	answer is ministerial correction date of answer 19/10/2015 answer text <p>Routine testing of babies for Group B Streptococcus (GBS) infection is not recommended. Therefore, no cost benefit assessment has been made by the Department on providing GBS tests to newborn babies.</p><br /><p>A search of the Department’s Ministerial correspondence database has identified 41 items of correspondence received since 1 January 2015 on GBS. This correspondence relates mainly to offering testing for GBS carriage in pregnancy.</p><br /><p>If a woman has previously had a baby with GBS, her maternity team will either monitor the health of her newborn baby closely for at least 12 hours after birth, or treat them with antibiotics until blood tests confirm whether or not GBS is present. The Department’s policy is not to offer antenatal screening for GBS carriage. This is based on advice from the UK National Screening Committee the body responsible for advising Ministers and the National Health Service in all four countries about all aspects of screening policy, and their advice is because there is insufficient evidence to demonstrate that the benefits to be gained from screening would outweigh the harms.</p> answering member constituency Ipswich answering member printed Ben Gummer grouped question UIN 10748 10749 question first answered 19/10/2015 14:14:57 answering member 3988 label Biography information for Ben Gummer
tabling member	411 label Biography information for Mr Barry Sheerman

420085

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that (a) his Department and (b) the NHS gives mental health parity of esteem with physical health.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	10684
answer	answer is ministerial correction date of answer 19/10/2015 answer text <p>We continue to take mental health as seriously as physical health and to hold the National Health Service to account for achieving the objectives set out in the NHS Mandate, ensuring that mental and physical health conditions are given equal priority. The Mandate makes clear that ‘everyone who needs it should have timely access to evidence-based services’.</p><br /><p>We have legislated for parity of esteem between mental and physical health via the Health and Social Care Act 2012.</p><br /><p>We have already expanded our world-leading psychological therapy services and we have invested over £120 million in order to introduce for the first time waiting times standards for mental health services from April 2015 – a very significant milestone on the road to parity. Next year we will invest £15 million into improving the provision of places of safety, in order to ensure that people in crisis receive assessments in appropriate premises, and not in police custody.</p><br /><p>We have made clear that each clinical commissioning group’s (CCG) spending on Mental Health should increase in real terms.</p><br /><p>NHS England’s published planning guidance for 2015/16 for commissioners made the expectation clear that each CCGs spend on mental health services in 2015/16 should increase in real terms, and grow by at least the same percentage as each CCG’s allocation increase.</p><br /><p>We will monitor this closely to ensure this happens.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 19/10/2015 14:35:52 answering member 1201 label Biography information for Alistair Burt
tabling member	411 label Biography information for Mr Barry Sheerman

420091

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of progress by the NHS on implementing the recommendations of the 17th Report of Session 2012-13 of the Public Accounts Committee, The management of adult diabetes services, HC 289; and if he will make a statement.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	10907
answer	answer is ministerial correction date of answer 19/10/2015 answer text <p><em>Treasury Minutes: progress report on the implementation of Government accepted</em> <em>recommendations of the Committee of Public Accounts - Sessions 2010-12, 2012-13 and 2013-14 </em>includes the most recent update on progress made by the NHS on implementing the recommendations of <em>the 17th Report of Session 2012-13 of the Public Accounts Committee, The management of adult diabetes services </em>and can be found at the following link:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/415600/48383_Cm_9034_Print_Ready.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/415600/48383_Cm_9034_Print_Ready.pdf</a></p><p><em>The management of adult diabetes services in the NHS: progress review</em>, due to be published by the National Audit Office on 21 October, will further assess progress made by the NHS on implementing these recommendations.</p><p><strong></strong></p> answering member constituency Battersea answering member printed Jane Ellison question first answered 19/10/2015 14:38:37 answering member 3918 label Biography information for Jane Ellison
tabling member	411 label Biography information for Mr Barry Sheerman

420092

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes: Medical Treatments Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what comparative assessment he has made of uptake and use by the NHS of new treatments for people living with diabetes with health systems in other EU countries.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	10908
answer	answer is ministerial correction date of answer 19/10/2015 answer text <p>The Office of Health Economics (OHE) report <em>International Comparison of Medicines Usage: Quantitative Analysis</em>, published last year, showed that uptake of newer and more expensive drugs to treat diabetes was lower than comparator countries. However, uptake of more established therapies was considerably higher.</p><p>It is important to note that high use of drugs does not mean more people are cured. There are a number of legitimate factors which influence usage, and therefore variation, such as populations with differing health needs. The Research and Development (RAND) Europe report <em>International variation in drugs usage: an exploratory analys</em>i<em>s</em>, published at the same time as the OHE report – seeks to define some of these factors and can be found at the link below:</p><br /><p><a href="http://www.rand.org/content/dam/rand/pubs/research_reports/RR800/RR899/RAND_RR899.pdf" target="_blank">http://www.rand.org/content/dam/rand/pubs/research_reports/RR800/RR899/RAND_RR899.pdf</a></p><br /><p>Our focus is on tackling unjustified variation where it exists.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 19/10/2015 13:08:36 answering member 3918 label Biography information for Jane Ellison
tabling member	411 label Biography information for Mr Barry Sheerman

419542

registered interest
date	17/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to increase public understanding of diabetes and its symptoms.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	10561
answer	answer is ministerial correction date of answer 12/10/2015 answer text <p>Change4Life, Public Health England’s (PHE) social marketing programme aimed at families with children aged 5 to 11 gives advice about healthy lifestyles in order to lower the risks of diseases such as type 2 diabetes, some cancers and heart disease. More than 2.7 million people have engaged with the campaign.</p><p>PHE is currently developing a social marketing campaign for adults about improving their own health, encouraging them to make a number of lifestyle changes including taking more exercise, improving diet, stopping smoking and reducing alcohol consumption.</p><p>The Department, building on the National Diabetes Prevention Programme, has committed to improving the outcomes for those with and at risk of diabetes. We will announce our plans in due course.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/10/2015 11:05:15 answering member 3918 label Biography information for Jane Ellison
tabling member	411 label Biography information for Mr Barry Sheerman

419543

registered interest
date	17/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Diabetes: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to improve the diagnosis and treatment of diabetes in children under five.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	10570
answer	answer is ministerial correction date of answer 12/10/2015 answer text <p>We are supporting the improvement of diagnosis and treatment of children with diabetes through a national best practice tariff, which sets out the standards of care and services that should be in place for children and young people in diabetes services. A round of peer review of all units providing care for children with diabetes was completed in September 2014. Through the Healthcare Quality Improvement Partnership we support the dedicated National Paediatric Diabetes Audit.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/10/2015 11:22:34 answering member 3918 label Biography information for Jane Ellison
tabling member	411 label Biography information for Mr Barry Sheerman

417310

registered interest
date	07/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his policy is on the introduction of user charges in the NHS.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	9091
answer	answer is ministerial correction date of answer 15/09/2015 answer text <p>The Government remains committed to the principles of the National Health Service, enshrined in the NHS Constitution, that access to NHS services is based on clinical need, not the ability to pay, and we have previously ruled out introducing charges.</p><p> </p><p> </p><p> </p><p>The Government has committed to fully meeting the additional funding requirement – £8 billion per year over and above inflation by 2020-21 – identified by the Five Year Forward View.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 9092 question first answered 15/09/2015 11:42:33 answering member 1201 label Biography information for Alistair Burt
tabling member	411 label Biography information for Mr Barry Sheerman

417311

registered interest
date	07/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential merits and demerits of introducing user charges in the NHS.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	9092
answer	answer is ministerial correction date of answer 15/09/2015 answer text <p>The Government remains committed to the principles of the National Health Service, enshrined in the NHS Constitution, that access to NHS services is based on clinical need, not the ability to pay, and we have previously ruled out introducing charges.</p><p> </p><p> </p><p> </p><p>The Government has committed to fully meeting the additional funding requirement – £8 billion per year over and above inflation by 2020-21 – identified by the Five Year Forward View.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 9091 question first answered 15/09/2015 11:42:33 answering member 1201 label Biography information for Alistair Burt
tabling member	411 label Biography information for Mr Barry Sheerman